In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2522-8307
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
In silico prediction and structure-based multitargeted molecular docking analysis of selected bioactive compounds against mucormycosis ; volume:46 ; number:1 ; day:31 ; month:1 ; year:2022 ; pages:1-21 ; date:12.2022
Bulletin of the National Research Centre / al- Markaz al-Qaumī li-'l-Buḥūṭ; 46, Heft 1 (31.1.2022), 1-21, 12.2022
- Urheber
-
Madanagopal, Premnath
Ramprabhu, Nagarjun
Jagadeesan, Rahul
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42269-022-00704-4
- URN
-
urn:nbn:de:101:1-2022050820461267945265
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Madanagopal, Premnath
- Ramprabhu, Nagarjun
- Jagadeesan, Rahul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glide XP fragment docking and structurebased pharmacophores
In silico structure-based approaches to design Mdmx inhibitors
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands
Gastrointestinal Mucormycosis
Colonic mucormycosis
Structure-based design of drugs and other bioactive molecules : tools and strategies
In silico docking of urokinase plasminogen activator and integrins
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Structure-based design, docking and binding free energy calculations of A366 derivatives as spindlin1 inhibitors
Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors
Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach
In silico molecular GRIP docking of some secondary metabolites combating diabesity
Glide XP fragment docking and structurebased pharmacophores
In silico structure-based approaches to design Mdmx inhibitors
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands
Gastrointestinal Mucormycosis
Colonic mucormycosis
Structure-based design of drugs and other bioactive molecules : tools and strategies
In silico docking of urokinase plasminogen activator and integrins
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Structure-based design, docking and binding free energy calculations of A366 derivatives as spindlin1 inhibitors
Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors
Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach
In silico molecular GRIP docking of some secondary metabolites combating diabesity
Glide XP fragment docking and structurebased pharmacophores
In silico structure-based approaches to design Mdmx inhibitors
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands
Gastrointestinal Mucormycosis
Colonic mucormycosis
Structure-based design of drugs and other bioactive molecules : tools and strategies
In silico docking of urokinase plasminogen activator and integrins
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Structure-based design, docking and binding free energy calculations of A366 derivatives as spindlin1 inhibitors
Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors
Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach